Strengthening Pharmacovigilance Systems in a Rapidly Evolving Regulatory Landscape
As global health authorities continue to tighten safety expectations, life sciences companies must reassess and strengthen their pharmacovigilance frameworks. This article explores practical strategies to maintain compliance while ensuring patient safety across markets.

